Dr. Reddy's Labs has offloaded its subsidiary Svaas Wellness for INR 2.23 crore to Enspirit Tech, a company not related to the pharmaceutical giant. This sale accounted for less than 1% of their total revenue in the fiscal year 2025.

Pharmaceutical companies like Dr. Reddy's and Lupin in India are integrating Artificial Intelligence (AI) into their operations for drug discovery, trials, and manufacturing. A discussion on AI's influence within the pharmaceutical sector was held with experts from PwC India, Dr. Reddy's, and Lupin by The Economic Times.